Solana Co — Director's Dealing 2021

Jun 15, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT)
CIK: 0001610853
Period of Report: 2021-06-14

Reporting Person: ANDREEFF DANE (Director, President and CEO, 10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-14	Stock Option (Right to Buy)	$15.57	A	195750	Acquired	2031-06-13	Common Stock (195750)	Direct

Footnotes

F1: Grant to the Reporting Person of a stock option to purchase 261,000 shares of common stock under the Issuer's 2018 Omnibus Incentive Plan. 25% of the shares are fully vested as of the grant date; 25% of the shares are granted, which will be reported when earned, will vest based on a performance condition; of the remaining shares, 25% of such number remaining shall vest on the one year anniversary of the grant date, and the remainder shall vest in thirty-six successive equal monthly installments on the last day of each full month, subject to the Reporting Perosn's continuous service through each applicable vesting period.